LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,189,000 | +6.7% | 30,068 | +0.5% | 0.01% | 0.0% |
| Q2 2021 | $3,925,000 | -10.7% | 29,921 | +3.8% | 0.01% | -16.7% |
| Q1 2021 | $4,395,000 | -34.7% | 28,826 | -57.4% | 0.01% | -33.3% |
| Q4 2020 | $6,727,000 | +81.9% | 67,644 | +74.3% | 0.02% | +38.5% |
| Q3 2020 | $3,699,000 | -9.1% | 38,807 | +6.7% | 0.01% | -18.8% |
| Q2 2020 | $4,069,000 | +67.4% | 36,383 | +8.8% | 0.02% | +23.1% |
| Q1 2020 | $2,431,000 | -2.3% | 33,426 | +40.2% | 0.01% | 0.0% |
| Q4 2019 | $2,487,000 | +328.8% | 23,847 | +309.0% | 0.01% | +333.3% |
| Q3 2019 | $580,000 | -12.9% | 5,831 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $666,000 | +85.5% | 5,831 | +104.3% | 0.00% | +100.0% |
| Q1 2019 | $359,000 | – | 2,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |